Daily ideas

CPKC grew Q2 2026 revenue 13% to C$4.16 billion while its core operating ratio worsened to 61.6%; Q3 tests whether grain volumes can outrun the coal decline.

Pfizer earned $0.77 adjusted EPS on $15.03 billion of Q2 2026 revenue; Q3 tests whether fall COVID sales of at least $1.3 billion keep its $4 billion outlook intact.

Sanofi grew Q2 2026 sales 17.8% at CER to €11.6 billion as Dupixent topped €5 billion; Q3 tests whether Dupixent sales and margins hold without one-offs.

Howmet grew Q2 2026 revenue 24% to $2.55 billion at a 32.1% adjusted EBITDA margin; Q3 tests whether Engine Products can hold its 37.7% margin while adding staff fast.

Huntington's Q2 2026 net interest margin slipped to 3.21% as deposit costs rose to 1.88%; Q3 results test whether Cadence deposit repricing lifts the margin off its trough.

Teledyne posted record Q2 2026 sales of $1.66 billion, up 9.8%, with backlog at $5.18 billion; Q3 tests whether imaging margins hold above 24% as tariff refunds fade.

After the eSLR rule eased, Goldman's equities financing revenue rose 96%, JPMorgan cut buybacks to redeploy capital, and Citi's prime balances grew over 40%.

Nucor earned $5.04 a share in Q2 2026 on record 7.1 million-ton mill shipments; Q3 tests whether higher steel prices can replace a $130 million one-time raw-material refund.

ICE posted Q2 2026 net revenue of $2.67 billion, up 5%, with a 61% adjusted operating margin; Q3 tests whether 31% higher futures volume turns into revenue at existing fees.

Crown Castle posted Q2 2026 site rental revenue of $967 million, down 4%, and AFFO of $1.13 a share; Q3 tests whether core leasing accelerates as the DISH drag widens.

Mondelez grew Q2 2026 revenue 4.1% to $9.36 billion as adjusted operating income fell 6.1%; Q3 tests whether European volumes and hedged cocoa costs let gross profit outrun reinvestment.

Equinix grew Q2 2026 revenue 16% to $2.625 billion, helped by $120 million of one-time xScale fees; Q3 tests whether MRR growth and a 51% margin hold without them.

Royal Caribbean grew Q2 2026 revenue 6.5% to $4.83 billion with $4.21 adjusted EPS as debt hit $22.8 billion; Q3 tests whether Caribbean demand offsets Europe to hold yields flat.

Amgen's Q2 2026 revenue rose 10% to $10.05 billion as Repatha grew 37%; Q3 tests whether growth brands still outrun Prolia erosion and rising R&D spend.

Hilton grew Q2 2026 RevPAR 3.9% and management and franchise fees 6.4% to $976 million; Q3 tests whether its roughly 4% RevPAR guide reflects durable demand or a World Cup lift.

Shopify grew Q2 2026 revenue 34% to $3.58 billion and gross profit 31%; Q3 tests whether payments-led growth keeps gross profit on guidance as loan losses rise.

Arm's fiscal Q1 2027 revenue rose 22% to $1.29 billion with a 41% non-GAAP margin; Q2 tests whether data center royalties offset weaker smartphone shipments.

OFAC's General License 135 lets Russian diesel land in the US until April 2027; NY Harbor diesel fell about 4.5%, which could ease fuel costs for JetBlue and Star Group.

Berkshire Hathaway lifted Q2 2026 operating earnings 16.3% to $12.98 billion as GEICO underwriting profit fell to $994 million; Q3 tests whether GEICO pricing can catch bodily injury claim costs.